Cancer Protein Description

This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.


Protein Name: MLLT3
Gene Name: MLLT3
Protein Full Name: Protein AF-9
Alias: AF9; AF-9; ALL1 fused gene from chromosome 9; Myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila); Myeloid/lymphoid or mixed-lineage leukemia (trithorax homologue, Drosophila); Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3; Translocated to, 3 (AF9); YEATS domain-containing 3; YEATS3
Mass (Da): 63351
Number AA: 568
UniProt ID: P42568
Locus ID: 4300
COSMIC ID: MLLT3
Gene location on chromosome: 9p22
Cancer protein type: OP
Effect of cancer mutation on protein: GAIN
Effect of active protein on cancer: PROMOTES
Number of cancer specimens: 20239
Percent of cancer specimens with mutations: 0.84
Deregulated in translocations: Translocation t(9;11) (p22;q23)-->MLL -AF9 in ANLL
Normal role description: MLLT3 is a transcriptional activator, and translocations of the gene with AF9 have been found in M5/M4 de novo- and therapy related ANLL.
Commentary on involvement of protein in cancer: 2/145 lung- and 1/59 ovarian cancer samples were mutated (Mis-sense) (Sanger COSMIC)


Provide the gene name, protein name, UniProt ID or Locus ID as a search term. Click on Retrieve Info button to obtain information on the selected cancer protein.